Letter to the Editor in response to "Response to Kovanen PT, et al. Letter to the Editor" for original article COVID-19 increases risk of myocardial infarction in persons with familial hypercholesterolemia with or without ASCVD.
作者信息
Myers Kelly D, Wilemon Katherine, McGowan Mary P, Howard William, Staszak David, Rader Daniel J
机构信息
The FH Foundation, 110 Chelton Circle, Winter Park, FL 32789, United States.
Atomo, Inc., 108 Wild Basin, Suite 250, West Lake Hills, TX 78746, United States.
出版信息
Am J Prev Cardiol. 2021 Sep;7:100225. doi: 10.1016/j.ajpc.2021.100225. Epub 2021 Jul 20.
Abstract
摘要
相似文献
1
Letter to the Editor in response to "Response to Kovanen PT, et al. Letter to the Editor" for original article COVID-19 increases risk of myocardial infarction in persons with familial hypercholesterolemia with or without ASCVD.致编辑的信，作为对关于原始文章“COVID-19增加家族性高胆固醇血症患者（无论有无动脉粥样硬化性心血管疾病）心肌梗死风险”的“对科瓦宁PT等人致编辑的信的回复”的回应。
Am J Prev Cardiol. 2021 Sep;7:100225. doi: 10.1016/j.ajpc.2021.100225. Epub 2021 Jul 20.
2
Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).预测家族性高胆固醇血症中的心血管事件：SAFEHEART 登记研究（西班牙家族性高胆固醇血症队列研究）。
Circulation. 2017 May 30;135(22):2133-2144. doi: 10.1161/CIRCULATIONAHA.116.024541. Epub 2017 Mar 8.
3
Coronary Artery Calcium and Cardiovascular Events in Patients With Familial Hypercholesterolemia Receiving Standard Lipid-Lowering Therapy.家族性高胆固醇血症患者接受标准降脂治疗后的冠状动脉钙和心血管事件。
JACC Cardiovasc Imaging. 2019 Sep;12(9):1797-1804. doi: 10.1016/j.jcmg.2018.09.019. Epub 2018 Nov 15.
4
Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry.家族性高胆固醇血症成年患者的纵向低密度脂蛋白胆固醇目标达标与心血管结局：CASCADE FH 登记研究。
Atherosclerosis. 2019 Oct;289:85-93. doi: 10.1016/j.atherosclerosis.2019.08.007. Epub 2019 Aug 19.
5
Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk.家族性高胆固醇血症的基因检测：对诊断、治疗和心血管风险的影响。
Eur J Prev Cardiol. 2019 Aug;26(12):1262-1270. doi: 10.1177/2047487319829746. Epub 2019 Feb 12.
6
Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).家族性高胆固醇血症中的冠心病、外周动脉疾病和中风：来自SAFEHEART注册研究（西班牙家族性高胆固醇血症队列研究）的见解
Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):2004-10. doi: 10.1161/ATVBAHA.116.307514. Epub 2016 Jul 21.
7
Longitudinal treatment patterns among US patients with atherosclerotic cardiovascular disease or familial hypercholesterolemia initiating lipid-lowering pharmacotherapy.美国患有动脉粥样硬化性心血管疾病或家族性高胆固醇血症并开始降脂药物治疗的患者的纵向治疗模式。
J Clin Lipidol. 2016 Nov-Dec;10(6):1470-1480.e3. doi: 10.1016/j.jacl.2016.09.002. Epub 2016 Sep 13.
8
Familial hypercholesterolemia and cardiovascular disease in older individuals.家族性高胆固醇血症与老年人群的心血管疾病
Atherosclerosis. 2021 Feb;318:32-37. doi: 10.1016/j.atherosclerosis.2020.12.012. Epub 2020 Dec 19.
9
In pediatric familial hypercholesterolemia, lipoprotein(a) is more predictive than LDL-C for early onset of cardiovascular disease in family members.在儿科家族性高胆固醇血症中，脂蛋白(a)比 LDL-C 更能预测家族成员心血管疾病的早发。
J Clin Lipidol. 2018 Nov-Dec;12(6):1445-1451. doi: 10.1016/j.jacl.2018.07.014. Epub 2018 Jul 31.
10
Paternal inheritance predicts earlier cardiovascular event onset in patients with familial hypercholesterolemia.父系遗传可预测家族性高胆固醇血症患者心血管事件的更早发生。
Atherosclerosis. 2021 Jul;329:9-13. doi: 10.1016/j.atherosclerosis.2021.06.006. Epub 2021 Jun 11.
本文引用的文献
1
Association between antecedent statin use and severe disease outcomes in COVID-19: A retrospective study with propensity score matching.他汀类药物使用与 COVID-19 严重疾病结局的关联：一项基于倾向评分匹配的回顾性研究。
J Clin Lipidol. 2021 May-Jun;15(3):451-459. doi: 10.1016/j.jacl.2021.03.002. Epub 2021 Mar 6.
2
Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19.COVID-19 住院患者中使用他汀类药物前史与死亡率降低的关联。
Nat Commun. 2021 Feb 26;12(1):1325. doi: 10.1038/s41467-021-21553-1.
3
Association between statin use and outcomes in patients with coronavirus disease 2019 (COVID-19): a nationwide cohort study.他汀类药物使用与 2019 冠状病毒病（COVID-19）患者结局的关系：一项全国性队列研究。
BMJ Open. 2020 Dec 4;10(12):e044421. doi: 10.1136/bmjopen-2020-044421.
4
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.意大利伦巴第地区重症监护病房中 COVID-19 患者死亡的相关危险因素。
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355. doi: 10.1001/jamainternmed.2020.3539.
5
In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19.住院期间使用他汀类药物与 COVID-19 患者的死亡率降低相关。
Cell Metab. 2020 Aug 4;32(2):176-187.e4. doi: 10.1016/j.cmet.2020.06.015. Epub 2020 Jun 24.
Zotero 插件